MedTrace Logo

Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder

NCT01271244 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2019-05-07

Study results available
· View outcomes & findings →

Summary

The study looked at relationship between escitalopram and heart rate variability and QT variability in veterans with PTSD.

Conditions

Interventions

DRUG

Escitalopram

10-20mg daily for 12 weeks

Sponsors & Collaborators

  • Forest Laboratories

    collaborator INDUSTRY

  • VA Nebraska Western Iowa Health Care System

    lead FED

Principal Investigators

  • Sriram Ramaswamy, MD · Department of Veterans Affairs/NWIHCS

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2013-06-30
Completion
2013-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01271244 on ClinicalTrials.gov